ID
22319
Description
Study ID: 100151 Clinical Study ID: EGF100151 Study Title: A Phase III, Randomized, Open-label, Multicenter Study Comparing GW572016 and Capecitabine (XELODA) versus Capecitabine in Women with Refractory Advanced or Metastatic Breast Cancer Clinicaltrials.gov Identifier: NCT00078572 https://clinicaltrials.gov/ct2/show/NCT00078572 Procedure: Disease History Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: lapatinib Trade Name: Tyverb,Tykerb,Tycerb Study Indication: Breast Cancer; Neoplasms, Breast
Link
https://clinicaltrials.gov/ct2/show/NCT00078572
Keywords
Versions (1)
- 5/29/17 5/29/17 -
Uploaded on
May 29, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
XELODA and Lapatinib Advanced or Metastatic Breast Cancer Disease History NCT00078572
XELODA and Lapatinib Advanced or Metastatic Breast Cancer Disease History NCT00078572
Description
Prior Anti-Cancer Surgery Screening
Alias
- UMLS CUI-1
- C0543467
- UMLS CUI-2
- C0920425
Description
received surgery for the cancer
Data type
text
Alias
- UMLS CUI [1,1]
- C0543467
- UMLS CUI [1,2]
- C0920425
Description
If YES, record in chronological order below:
Data type
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0543467
Description
Procedure
Data type
text
Alias
- UMLS CUI [1]
- C0184661
Description
Prior Anti-Cancer Systemic Therapy Screening
Alias
- UMLS CUI-1
- C1515119
- UMLS CUI-2
- C0920425
Description
prior anti-cancer systemic therapy for the cancer
Data type
text
Alias
- UMLS CUI [1,1]
- C1515119
- UMLS CUI [1,2]
- C0920425
Description
If NO, leave remainder of page blank. If YES, record, in chronological order, all prior therapies for the cancer under study.
Data type
text
Alias
- UMLS CUI [1,1]
- C0040808
- UMLS CUI [1,2]
- C0237753
Description
Therapy
Data type
text
Alias
- UMLS CUI [1]
- C1515119
Description
Intent
Data type
text
Alias
- UMLS CUI [1,1]
- C1283828
- UMLS CUI [1,2]
- C1515119
Description
No. of cycles
Data type
text
Alias
- UMLS CUI [1,1]
- C1515119
- UMLS CUI [1,2]
- C0750480
Description
Total cumulative dose of Anthracycline
Data type
float
Measurement units
- mg/m2
Alias
- UMLS CUI [1,1]
- C0003234
- UMLS CUI [1,2]
- C3174092
- UMLS CUI [2]
- C1515119
Description
Date started
Data type
date
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C1515119
Description
Date stopped
Data type
date
Alias
- UMLS CUI [1,1]
- C0806020
- UMLS CUI [1,2]
- C1515119
Description
Best response
Data type
text
Alias
- UMLS CUI [1,1]
- C2986560
- UMLS CUI [1,2]
- C1515119
Description
Date of progression
Data type
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0242656
- UMLS CUI [1,3]
- C1515119
Description
Prior Anti-Cancer Radiotherapy Screening
Alias
- UMLS CUI-1
- C1522449
- UMLS CUI-2
- C0920425
Description
prior radiotherapy for the cancer
Data type
text
Alias
- UMLS CUI [1,1]
- C1522449
- UMLS CUI [1,2]
- C0920425
Description
If YES, record in chronological order below.
Data type
text
Alias
- UMLS CUI [1,1]
- C1515974
- UMLS CUI [1,2]
- C1522449
Description
Date started
Data type
date
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C1522449
Description
Date stopped
Data type
date
Alias
- UMLS CUI [1,1]
- C0806020
- UMLS CUI [1,2]
- C1522449
Description
Estimated total dose amount
Data type
float
Alias
- UMLS CUI [1,1]
- C1522449
- UMLS CUI [1,2]
- C1265611
Description
Estimated total dose units
Data type
text
Alias
- UMLS CUI [1,1]
- C1522449
- UMLS CUI [1,2]
- C0178602
- UMLS CUI [1,3]
- C1519795
Description
Best response
Data type
text
Alias
- UMLS CUI [1,1]
- C2986560
- UMLS CUI [1,2]
- C1522449
Similar models
XELODA and Lapatinib Advanced or Metastatic Breast Cancer Disease History NCT00078572
C1710477 (UMLS CUI-2)
C0678222 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
C0678222 (UMLS CUI [1,2])
C1719707 (UMLS CUI [1,2])
C3172269 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
C0678222 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0678222 (UMLS CUI [2])
C0920425 (UMLS CUI-2)
C0920425 (UMLS CUI [1,2])
C0543467 (UMLS CUI [1,2])
C0920425 (UMLS CUI-2)
C0920425 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0750480 (UMLS CUI [1,2])
C3174092 (UMLS CUI [1,2])
C1515119 (UMLS CUI [2])
C1515119 (UMLS CUI [1,2])
C1515119 (UMLS CUI [1,2])
C0242656 (UMLS CUI [1,2])
C1515119 (UMLS CUI [1,3])
C0920425 (UMLS CUI-2)
C0920425 (UMLS CUI [1,2])
C1522449 (UMLS CUI [1,2])
C1522449 (UMLS CUI [1,2])
C1522449 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C1519795 (UMLS CUI [1,3])